From: Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc
 | DWA | VMATCDR |  | |
---|---|---|---|---|
 | mean ± SD | mean ± SD | p-value | |
Prostate | MCS | 0.46 ± 0.02 | 0.49 ± 0.06 | p = 0.42 |
Ɣ-index (%) | 98.17 ± 0.86 | 98.4 ± 1.71 | p = 0.97 | |
Oligometastatic cases | MCS | 0.28 ± 0.05 | 0.32 ± 0.05 | p = 0.03 |
Ɣ-index (%) | 98.72 ± 1.13 | 98.42 ± 1.42 | p = 0.08 | |
Centrally- located NSCLC | MCS | 0.33 ± 0.07 | 0.35 ± 0.09 | p = 0.34 |
Ɣ-index (%) | 99.2 ± 0.91 | 98.54 ± 1.83 | p = 0.96 | |
LAPC | MCS | 0.46 ± 0.04 | 0.44 ± 0.04 | p = 0.29 |
Ɣ-index (%) | 98.1 ± 0.74 | 98.20 ± 0.70 | p = 0.80 |